Splice Bio
SpliceBio develops genetic medicines through its innovative Protein Splicing platform, focusing on gene therapies for genetic diseases. The company aims to address conditions caused by mutations in large genes, utilizing proprietary technologies to create novel treatment options. SpliceBio's pipeline includes programs targeting specific genetic disorders, such as Stargardt Disease. By leveraging its expertise in protein splicing, the company seeks to advance the field of gene therapy and improve patient outcomes. Through ongoing research and development, SpliceBio contributes to the understanding and treatment of complex genetic conditions.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Splice Bio use?+
We have not yet detected technologies for Splice Bio.
What industry is Splice Bio in?+
Splice Bio operates in the Biotechnology industry.
Where is Splice Bio based?+
Splice Bio is headquartered in Spain.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026